#1 Clinical Trials Search in Europe

Fexofenadine

This article examines the use of fexofenadine, an antihistamine medication, in various clinical trials. These studies investigate fexofenadine’s bioequivalence, pharmacokinetics, interactions with other substances, and potential new applications beyond allergy treatment. The trials provide valuable insights into the drug’s effectiveness, safety profile, and optimal dosing across different patient populations.

Table of Contents

What is Fexofenadine?

Fexofenadine is a medication used to treat allergy symptoms. It belongs to a class of drugs called antihistamines, specifically third-generation H1 receptor antagonists. Fexofenadine is known by various brand names, including Allegra and Telfast[1]. This medication is designed to provide relief from allergy symptoms without causing drowsiness, making it a popular choice for many patients[2].

Uses of Fexofenadine

Fexofenadine is primarily used to treat symptoms associated with allergies. These symptoms may include:

  • Seasonal allergic rhinitis: This refers to allergies that occur during specific seasons, often called “hay fever”.
  • Perennial allergic rhinitis: These are year-round allergies, often caused by indoor allergens like dust mites or pet dander[3].
  • Chronic idiopathic urticaria: This is a condition characterized by recurring hives (itchy, raised welts on the skin) with no known cause[4].

Fexofenadine helps alleviate symptoms such as sneezing, runny nose, itchy or watery eyes, and itchy throat or nose[3].

How Fexofenadine Works

Fexofenadine works by blocking the effects of histamine, a substance your body produces during an allergic reaction. Histamine is responsible for many allergy symptoms, such as sneezing, itching, and runny nose. By blocking histamine receptors, fexofenadine helps reduce these symptoms[2].

Dosage Forms

Fexofenadine comes in various forms and strengths, including:

  • Tablets: Available in strengths such as 30 mg, 60 mg, 120 mg, and 180 mg[2][1].
  • Orally disintegrating tablets: These are tablets that dissolve in your mouth without needing water. They’re available in 30 mg strength[5].
  • Extended-release tablets: These provide a longer-lasting effect and are often combined with other medications like pseudoephedrine for additional symptom relief[6].

The appropriate dosage depends on the patient’s age, the condition being treated, and other factors. Always follow your healthcare provider’s instructions or the directions on the package label.

Side Effects and Safety

Fexofenadine is generally well-tolerated, but like all medications, it can cause side effects in some people. Common side effects may include:

  • Headache
  • Dizziness
  • Nausea
  • Drowsiness (although less common than with older antihistamines)

Serious side effects are rare but can occur. If you experience any unusual or severe symptoms, contact your healthcare provider immediately[1].

Special Considerations

There are some special considerations to keep in mind when taking fexofenadine:

  • Food interactions: Certain foods, particularly grapefruit juice, can affect how your body processes fexofenadine. This can lead to decreased effectiveness of the medication[7].
  • Kidney function: If you have kidney problems, your doctor may need to adjust your dosage of fexofenadine[8].
  • Pregnancy and breastfeeding: If you’re pregnant or breastfeeding, discuss the risks and benefits of fexofenadine with your healthcare provider.

Ongoing Research

While fexofenadine is well-established as an allergy medication, researchers continue to study its potential uses and effects. Some areas of ongoing research include:

  • Cardiac health: A study is investigating the potential effects of fexofenadine on heart health in patients who have had a heart attack. This research is exploring whether fexofenadine might help reduce heart fibrosis (scarring of the heart tissue) after a heart attack[4].
  • Pharmacokinetics: Researchers are studying how fexofenadine is processed by the body, including how it’s affected by factors like food, kidney function, and genetic variations[7][8].

These studies may lead to new uses for fexofenadine or improved understanding of how to use it most effectively in different patient populations.

Aspect Details
Study Types Bioequivalence, pharmacokinetics, drug interactions, new applications
Dosage Forms Standard tablets (30-360 mg), orally disintegrating tablets, extended-release formulations
Conditions Studied Healthy volunteers, ST-segment Elevation Myocardial Infarction (STEMI), hemodialysis patients
Key Measurements Area Under the Curve (AUC), Cmax, Left Ventricular Ejection Fraction (LVEF), Late Gadolinium Enhancement (LGE)
Safety Assessments Adverse events, vital signs, laboratory tests, organ system reactions
Special Considerations Fasting vs. fed conditions, interactions with grapefruit juice, effects of dialysis

FAQ

  • What is fexofenadine and what is it commonly used for? Fexofenadine is a third-generation H1 receptor antagonist, commonly known as an antihistamine. It is primarily used to treat allergic conditions such as seasonal allergic rhinitis (hay fever) and chronic idiopathic urticaria (hives).
  • How is fexofenadine being studied in clinical trials? Clinical trials are investigating various aspects of fexofenadine, including its bioequivalence to brand-name versions, its pharmacokinetics under different conditions (e.g., fasting vs. fed states), its interactions with other substances like grapefruit juice, and its potential use in new applications such as treating cardiac fibrosis after myocardial infarction.
  • What are some of the different dosage forms of fexofenadine being studied? The clinical trials examine various dosage forms of fexofenadine, including standard tablets (ranging from 30 mg to 360 mg), orally disintegrating tablets, and extended-release formulations combined with other drugs like pseudoephedrine.
  • Are there any new potential uses for fexofenadine being explored? Yes, one clinical trial is investigating the use of fexofenadine in patients with acute myocardial infarction (heart attack). This study aims to evaluate if fexofenadine can help reduce cardiac fibrosis and improve heart function in these patients.
  • How is the safety of fexofenadine being assessed in these trials? Safety assessments in these trials typically involve monitoring adverse events, changes in vital signs, laboratory tests (including hematology, biochemistry, and liver function), and in some cases, specific evaluations of heart, nervous system, mental system, digestive system, and immune system reactions.

Ongoing Clinical Trials on Fexofenadine

  • Study of felzartamab compared to placebo in adults with IgA nephropathy

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria Croatia Czechia France Germany +5

  • Study on the Effectiveness and Safety of Dupilumab for Adults with Chronic Itch of Unknown Cause

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Hungary Italy Poland Spain

  • Study to Evaluate mRNA-3210 for Safety and Tolerability in Patients with Phenylketonuria

    Not recruiting

    1 1 1
    Investigated drugs:
    France Italy Spain

Glossary

  • Bioequivalence: A comparison of the biological equivalence of two products with the same active ingredient. In drug testing, it refers to the comparison between a generic drug and a brand-name drug to ensure they have the same effectiveness.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion. This helps determine the onset, duration, and intensity of a drug's effect.
  • Fasting conditions: A state where a person has not eaten for a certain period before taking a medication. This is often used in clinical trials to standardize drug absorption and eliminate food effects.
  • Crossover study: A type of clinical trial where participants receive different treatments or interventions in a specific order, allowing each participant to serve as their own control.
  • Area Under the Curve (AUC): A measure used in pharmacokinetics to represent the total exposure to a drug over time. It is calculated by plotting the drug concentration in blood plasma against time.
  • Cmax: The maximum concentration of a drug in the blood plasma after administration. It is an important parameter in pharmacokinetics studies.
  • ST-segment Elevation Myocardial Infarction (STEMI): A type of heart attack where there is a complete blockage of a coronary artery, causing a large area of heart muscle damage.
  • Late Gadolinium Enhancement (LGE): A technique used in cardiac magnetic resonance imaging to detect and quantify myocardial fibrosis or scarring.
  • Left Ventricular Ejection Fraction (LVEF): A measurement of how much blood the left ventricle pumps out with each contraction, used to assess heart function.
  • Furanocoumarin: A class of organic chemical compounds found in certain plants, including grapefruit, that can interact with drug metabolism in the body.

References

  1. https://clinicaltrials.gov/study/NCT01767272
  2. https://clinicaltrials.gov/study/NCT01066754
  3. https://clinicaltrials.gov/study/NCT00741897
  4. https://clinicaltrials.gov/study/NCT06548204
  5. https://clinicaltrials.gov/study/NCT01888718
  6. https://clinicaltrials.gov/study/NCT01133470
  7. https://clinicaltrials.gov/study/NCT01526213
  8. https://clinicaltrials.gov/study/NCT03078777